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ABSTRACT 
 
Background 
 Moyamoya syndrome is a chronic and progressive disorder, which affects the 
cerebral vasculature, especially at the Circle of Willis.  Pathologically, the changes occur 
in the vessel and wall and lead to progressive narrowing and eventual occlusion of the 
internal carotid artery and possibly additional vessels.  As the disorder progresses, 
decreased cerebral blood flow leads to dangerous ischemic events in pediatric patients, 
especially transient ischemic attacks and stroke.  Surgery is necessary to reestablish 
proper blood flow however; prior to this a diagnostic cerebral angiogram is performed to 
visualize the blood vessels affected.  During this procedure, intravenous (IV) anesthetic 
induction is typically used.  However, IV access and insertion are likely to agitate 
children, leading to anxiety and crying.  In moyamoya patients, crying and subsequent 
hyperventilation is a known trigger of ischemic events.   Therefore, this study is 
investigating the safety of mask induction compared to IV for this procedure, which 
would help avoid episodes of crying. 
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Methods 
 Records from moyamoya patients admitted to Boston Children’s Hospital for a 
diagnostic cerebral angiogram during the period of 2007-2013 were analyzed 
retrospectively (n=98).  The main focus was data analysis between patients who 
underwent IV versus mask induction to determine if there was equivalence of safety 
based on hemodynamic parameters.  An unsafe blood pressure drop is clinically deemed 
as a 20% or greater drop from the patient’s baseline and this criteria was used when 
determining if a patient was a case (who experienced this unsafe event) or control. (who 
did not).  Additionally, other intraoperative variables were analyzed for possible 
correlation with hemodynamic stability.  Lastly, demographic patient information was 
gathered to gain an understanding of the population being analyzed.  Statistical analysis 
was performed for all results when possible to determine significance. 
Results 
 In the population analyzed (n=98), n=49 patients underwent IV and n=49 patients 
mask induction.  The proportion of patients who experienced an unsafe drop in blood 
pressure in both groups was statistically equivalent (p=0.65).  Additionally, the difference 
in magnitude of the average blood pressure drop experienced in case patients was not 
statistically significant (p=0.07).  A significant difference was found between case 
patients and the groups as a whole for both IV and mask induction.  Patients who 
experienced an unsafe drop in blood pressure had a significantly higher baseline blood 
pressure (p=0.03, 0.00, respectively).  Intraoperative variables analyzed showed no 
significant correlation to percent blood pressure drop.  
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Conclusion 
The data analysis performed to evaluate hemodynamic safety between IV and 
mask induction strongly demonstrated that the two methods are statistically equivalent.  
Based on these results, it is recommended that mask induction be considered an equally 
safe alternative for anesthetic induction in pediatric moyamoya patients undergoing 
diagnostic cerebral angiograms, one which may help avoid dangerous ischemic events in 
the peri-induction period. 
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INTRODUCTION 
Introduction to Moyamoya 
Moyamoya syndrome is a rare vasculopathy, which affects the cerebral vasculature.  
This chronic disorder leads to a progressive occlusion of vessels ultimately requiring 
surgical treatment.  The most serious complications associated with this syndrome 
include transient ischemic attacks (TIA) and stroke, which occur as a result of decreased 
cerebral perfusion (Iwama et al, 1996).  A physiological response to decreased cerebral 
perfusion includes the development of a basally located collateral vessel network.  This 
collateral network is a key diagnostic feature of this syndrome in cerebral angiographic 
findings and has a characteristic appearance of a “puff of smoke”- in Japanese, 
moyamoya (Smith and Scott 2005).   
Terminology to classify moyamoya can be confusing as some terms are used 
interchangeably.  Alone, moyamoya is a term used to describe vascular changes, which 
are observed in cerebral angiography. The syndrome has a variable presentation pattern 
and may affect the internal carotid arteries in a unilateral or bilateral fashion, which 
defines the syndrome and disease, respectively (Smith 2012).  However, the presence of 
bilateral vascular changes in a patient with a well-defined systemic disorder is referred to 
as moyamoya syndrome.   
Moyamoya is a very rare disorder with some patterns of predisposition.  It is most 
common in Japan with a prevalence of 6.03 per 100,000, and also has higher incidence 
rates in Korea and other Asian countries compared to the rest of the world.  (Parray et al., 
2011).  The disorder is also more common in females versus males with a ratio of 1.8:1.  
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(Parray et al., 2011).  The age distribution of the disorder is bimodal with peaks in the 
pediatric range at age 5 and in adults at 40. (Ryan et al., 2012)  The clinical complications 
of the disease are variable within these two populations.  While the most common serious 
complications observed in both populations are ischemic events, caused by a lack of 
oxygen, such as stroke and TIA, the adult population shows a higher frequency of 
hemorrhagic events, at a rate of 20% vs. 2.8%, respectively.  (Parray et al., 2011).  The 
hemorrhagic events are typically linked to the collateral vessel network, which is 
abnormal vasculature composed of thin and leaky vessel walls (Doi and Kikuta, 2010). 
 
Pathology and Etiology 
 Moyamoya vascular changes occur at major arteries in the Circle of Willis, a 
network of arteries, which is basally located and is a major source of the brain’s blood 
supply (Figure 1).  Specifically, moyamoya involves a unilateral or bilateral progressive 
stenosis of the distal portion of the internal carotid arteries (ICA).  Additionally, the 
proximal anterior cerebral artery (ACA) and middle cerebral artery (MCA) are affected to 
varying degrees (Smith 2012).  There are four pathological criteria found in moyamoya 
syndrome.  The first element is the stenosis and eventual occlusion of the lumen in the 
terminal ICA.  Second, similar changes to various degrees are apparent in other arteries 
of the Circle of Willis, including the ACA, MCA, and posterior communicating arteries.  
Next, there is the formation and visible appearance of many abnormal small vessels, 
which form the collateral network, located basally around the Circle of Willis.   Lastly, 
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there are also groups of small vessels observed in the innermost layer of the meninges 
and the pia mater. 
 
 
 
 
 
 
Figure 1.  Vessels of the Circle of Willis.  This diagram demonstrates 
the major cerebral vessels which form the Circle of Willis, a major 
source of the brain’s blood supply. Moyamoya changes occur at the 
terminal internal carotid artery either unilaterally or bilaterally.  The 
adjacent middle cerebral and posterior cerebral arteries may be affected 
in some cases. (Figure taken from Gray’s Anatomy, 37th edition). 
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 Initially, in 1957 moyamoya was classified as a hypoplasia of the bilateral ICA 
(Doi and Kikuta, 2010).  Although the pathogenesis of moyamoya remains unknown, 
since then, research has progressed and now more detailed studies of the pathology and 
histology of the disease are available.  The primary cause for occlusion of the arterial 
lumen is a fibrocellular thickening of the intima layer of the vessel wall.  Specifically, 
there is a hyperplasia of smooth muscle cells within the intima.  The vessels do not 
exhibit arteriosclerotic changes or the presence of inflammatory cells.  However, in rare 
cases, lipid deposits may be observed.   Other histological characteristics are waving of 
the internal elastic lamina and an attenuation of the media layer of the vessel wall (Doi 
and Kikuta, 2010).     
 Research has revealed the presence of several markers, which may help elucidate 
the pathogenesis of moyamoya changes.  Although the vessels do not show inflammatory 
changes, samples of cerebrospinal fluid (CSF) reveal increased levels of vascular-cell 
adhesion molecule type 1, E-selectin, and intercellular adhesion molecule type-1.  The 
presence of these molecules may indicate an underlying inflammation of the entire 
central nervous system.  (Parray et al., 2011).  Additionally, there is an elevated level of 
fibroblast growth factor in the CSF adding further evidence to the possibility of an 
underlying systemic process being the cause of the vasculopathy.  Lastly, in some 
moyamoya patients there have been observed similar abnormalities to pulmonary, renal, 
cardiac and pancreatic arteries. (Smith 2012) 
 Moyamoya syndrome also leads to vascular abnormalities outside of the Circle of 
Willis.  Most notable is the diagnostic feature of the disease, which is a basally located 
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collateral vessel network.  It is hypothesized that this network forms in response to 
hypoxic conditions that are a result of ischemia in regions of the brain that are 
hypoperfused.  To support this, research has found an increased number of endothelial 
progenitor cells (EPCs), which could play a role in angiogenesis of the new vessels.  
EPCs are stem cells, which are “programmed” to form new blood vessels through 
angiogenesis and to work in endothelial repair.  Unfortunately, the collateral vessels 
formed in moyamoya patients also have abnormal vessels walls.  Contrary to the 
thickened walls of arteries at the Circle of Willis, the collateral vessels have very thin and 
leaky walls.  This is an underlying cause of hemorrhagic events observed in some 
moyamoya patients, especially in the adult patient population.  For example, the rupture 
of collateral vessels can trigger an acute subdural hematoma, which is a type of 
intracranial hemorrhage.  
The etiology of the syndrome has yet to be elucidated but it is hypothesized to be 
of multifactorial inheritance with both genetic and environmental determinants (Smith 
and Scott 2005).  Occurrence in conjunction with congenital disorders, such as Down’s 
syndrome, supports the hypothesis of genetic determinacy.  Also, familial incidence 
occurs at a rate of 9% - 12% of cases.   Genetic studies of moyamoya in Japanese 
families suggest a link to chromosomes 3, 6, 8, 12, and 17 (Parray et al., 2011).  The 
linkage patterns suggest the disease is inherited in an autosomal dominant manner with 
low penetrance or in a polygenic manner.  
 Also, there is strong evidence to support the importance of environmental factors 
in a multi-factorial inheritance model (Table 1).  An example of an environmental 
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determinant is irradiation; patients who received radiation therapy have a higher risk of 
developing moyamoya syndrome (Smith, 2012).  Additionally, there are case studies of 
identical twins in which only one twin develops moyamoya, demonstrating that 
environmental, non-genetic factors play a role in disease development (Smith and Scott, 
2005).  There are also case reports of patients developing moyamoya syndrome following 
different infectious diseases (Smith and Scott 2005).  As the field of moyamoya research 
expands and gains awareness, hopefully extended efforts will help answer the questions 
of etiology so that targets for new treatments can be revealed.  
 
 
 
 
 
Table 1. Comorbidities associated with moyamoya syndrome.  This 
table depicts various medical conditions, which often coexist in 
moyamoya cases.  Some of the disorders listed have a genetic origin, 
fueling the hypothesis that moyamoya is a genetic disorder.  Others, such 
as radiation exposure, are environmental factors. (Taken from Smith and 
Scott, 2012.) 
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Diagnostic Procedures  
If a patient presents with symptoms associated with moyamoya syndrome various 
tests are conducted in order to confirm the diagnosis.  In children, these diagnostic steps 
typically begin upon presentation with symptoms of an ischemic event such as 
hemiparesis.   
The first step in the workup is a head computed tomography (CT) scan.  Signs of 
stroke in the CT scan include small areas of hypodensity located basally, in ischemic 
areas of the brain.  Also, although rare, CT can reveal evidence of hemorrhage from 
moyamoya vessels.  CT scanning is decreasing in prevalence in many centers, due to 
concerns for radiation exposure, particularly in pediatric patients.   
Next, if there are suggestive findings in the CT scan, a patient will undergo with 
magnetic resonance imaging (MRI)/magnetic resonance angiography (MRA).   Acute 
infarcts are visualized well using this technique, which is increasingly popular due to its 
non-invasive nature and lack of radiation.    The diagnostic features of moyamoya found 
using MRI/MRA are diminished flow voids in the internal carotid artery and the anterior 
and or/middle cerebral arteries.   Additionally, prominent collateral flow voids are 
visualized in the basal ganglia and thalamus regions of the cortex.  Experts believe that 
these findings are virtually diagnostic of moyamoya syndrome. 
However, despite the results obtained from MRI/MRA, the invasive cerebral 
angiography procedure remains the gold standard for both diagnosis and staging of 
moyamoya (Parray et al., 2011).  Angiographic findings are used to confirm the diagnosis 
of moyamoya syndrome.  Also, cerebral angiography is an important pre-operative step 
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because it allows clinicians to visualize the vessels affected by moyamoya and observe 
blood flow patterns throughout the brain.  Diagnostic findings for moyamoya syndrome 
in cerebral angiography include terminal occlusion of the internal carotid artery, 
unilaterally or bilaterally, and also, dilated collateral vessels developed at the base of the 
brain (Figure 1).  The dilated collateral vessel network is what is observed as the “puff of 
smoke” in cerebral angiography.   
 
 
 
  
 
 
Figure 2. Cerebral Angiography findings in moyamoya patient.  This 
figure shows pre-operative angiographic findings in a moyamoya patient. 
(A) The right hemisphere cerebral arteries are mostly normal, with some 
stenosis of the proximal ACA, indicated by the black arrow.  No 
moyamoya collateral vessels are observed.  (B) The left hemisphere 
vessels show significant occlusion, with the white arrow indicating 
occluded distal ICA and proximal MCA.  These findings indicate a 
Suzuki stage 3.  Furthermore, these findings allow clinicians to confirm 
the moyamoya diagnosis and prepare an operative plan based on the 
findings. (Taken from Togao et al., 2006) 
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Additionally, cerebral angiography is necessary to stage the patient’s disease and 
assign a traditionally used Suzuki Stage of 1-6, with a higher stage being correlated to a 
more severe moyamoya disease state (Table 2).  In first stage, occlusion of the internal 
carotid(s) has begun, however, physiological compensation for this stage has not yet 
occurred.  In the second stage, basal collateral vessels appear in the angiogram.  The third 
stage is a progression of this and is common in diagnosis because at this point there is a 
prominent basal collateral network, and the likelihood of symptomatic presentation 
increases.  In the fourth through sixth stage there is continued progressive occlusion of 
the internal carotid(s), culminating in the sixth stages with complete occlusion.  A 
marked feature of the fifth stage is the formation of an extracranial collateral network as a 
last effort to compensate for the lack of cerebral blood flow.  
 
 
 
 
 
Table 2. Suziki Stages of Moyamoya.  This table briefly highlights the 
key features of each stage of moyamoya progression, as defined by 
Suzuki initially.  The findings found using cerebral angiography are the 
basis for assigning disease grade to a patient.  This is one of several 
reasons that cerebral angiography remains the gold standard and a 
necessary step in moyamoya diagnosis.  (Taken from Parray et al., 2011) 
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Short-term Treatment Options 
Although some medical treatments are administered to moyamoya patients short-
term prior to revascularization surgery, none of them are viable solutions because they 
fail to halt progression or reverse occlusive vascular changes in major cerebral arteries.  
The lack of non-surgical treatment options is an area that hopefully will be addressed by 
progress in the research field.  Commonly administered medications include blood 
thinners and antiplatelet agents such as aspirin or ticlopidine.  These are administered to 
help reduce the risk of stroke.  Aspirin is dosed based on patient weight and a typical 
dose in children is 81 mg daily, however, some clinicians prefer to use low-molecular-
weight heparin instead of aspirin for antithrombic effects.  Low-molecular-weight 
heparin is also commonly used perioperatively due to its shorter half-life when compared 
to aspirin. A class of vasodilator drugs known as calcium channel blockers is 
occasionally used to treat severe headache.  However, this class must be used with 
caution due to its tendency to inducing hypotension, which this patient population cannot 
tolerate, as it can result in an increased chance of stroke.  Other medications may be 
administered based on a patient’s clinical presentation, for example, the administration of 
anticonvulsants for a patient presenting with seizures. 
However, administration of these medications in the absence of surgical treatment 
is ineffective for moyamoya treatment.  The 5-year risk for recurrent ipsilateral stroke is 
65% in symptomatic patients with unilateral involvement, and 85% in cases with bilateral 
involvement when the disorder is not treated surgically.  Therefore, to treat the symptoms 
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of moyamoya and prevent dangerous ischemic events, a surgery is required to increase 
the brain’s blood supply. 
 
Surgical Treatment Options 
Ultimately, a revascularization surgery, either direct or indirect, is necessary to re-
establish proper cerebral blood flow as the condition is chronic and there is no medical 
treatment available to reverse or halt its progression (Ryan et al., 2012).  The goal of 
different surgical approaches is the same in that they aim to create a new, effective blood 
supply to the ischemic cortex.  Both approaches use the external carotid circulation as a 
donor supply for blood vessels because these vessels are not affected by moyamoya.  
Surgery is recommended as soon as possible after a definite diagnosis has been made in 
the absence of acute medical complications.  The two classes of surgical approaches are 
direct and indirect revascularizations, with several specific surgeries in each class.  Both 
direct and indirect approaches have shown success with a similar rate and there is no 
standard procedure.  The decision is at the discretion of the surgeon and is based on the 
patient’s age, symptoms, and comorbidities.    
Direct revascularization surgery is a type of bypass surgery, which is most 
commonly used in adults.  An example of a direct revascularization procedure is a bypass 
surgery of the superficial temporal artery to the middle cerebral artery.  An advantage of 
this procedure and other direct surgeries is that there is a subsequent instant improvement 
in cerebral blood flow.  By the same token, however, the sudden increase in blood flow 
may lead to peri-operative complication such as microbleeds or stroke.  
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The indirect revascularization surgical approach brings existing richly 
vascularized tissue in contact with the brain and promotes growth of new blood vessels to 
increase supply to ischemic areas.  This approach is used in the treatment of the majority 
of pediatric patients.  One reason for this is that direct bypass is inherently challenging 
due to small vessel size in children and the indirect method avoids this problem.  Also, 
angiogenesis appears to be more successful in children when compared to adults.  The 
indirect approach relies on the pro-angiogenic environment of the ischemic brain and 
encourages the growth of an effective collateral vessel network to increase blood supply.  
One disadvantage of this approach is that the effects on blood supply are not immediate 
and it may take months to develop adequate collaterals and provide the intended 
symptomatic relief.  
 
Anesthetic Considerations for Moyamoya Syndrome Patients 
Due to the effects of moyamoya on the cerebral vasculature, the most common 
and also dangerous manifestation of moyamoya syndrome in pediatric patients is cerebral 
ischemia.  With this knowledge, it is important to take caution in perioperative care of 
moyamoya patients to avoid events that could trigger an ischemic event.  Specifically, 
efforts should be made to prevent hypocapnea, which leads to cerebral vasoconstriction, 
and hypotension (Iwama et al., 1996).  One precautionary action taken in some cases is 
the administration of premedication, such as midazolam, to decrease patient anxiety and 
help avoid crying and subsequent hyperventiliation.  Additionally, a clinical focus is to 
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maintain blood pressure near or above the baseline value while the patient is under 
anesthesia. (Parray et al., 2011). 
In pediatric patients one of the major causes of hyperventilation in the hospital 
setting is crying, and evidence shows that this can increase risk of perioperative stroke 
(Smith and Scott, 2005).  The physiological response to hyperventilation leads to 
hypocapnea and a cerebral vasculature response of vasoconstriction (Nomura et al., 
2001).  It is of utmost importance to avoid vasoconstriction in moyamoya patients as their 
major vessels already have constricted lumens (Parray et al., 2011).  Any further 
constriction could lead to an ischemic complication such as stroke or TIA (Nomura et al., 
2001).   
 
Investigating Hemodynamic Stability During Diagnostic Cerebral Angiogram 
As discussed previously, before a patient receives a necessary revascularization 
procedure, he or she must undergo a diagnostic cerebral angiogram to confirm diagnosis 
and so that physicians may visualize the state of the blood vessel.  Currently, there is no 
standard of care regarding what the best method of anesthetic induction is in this patient 
population for the cerebral angiography procedure.  
Anesthetic induction of patients may be achieved using intravenous (IV) or mask 
induction.  The first option is intravenous induction and may be accomplished with 
propofol, etomidate, or thiopental, with the most common anesthetic agent being propofol 
(Parray et al., 2011).  The second is mask induction with use of sevoflurane with or 
without nitrous oxide as an anesthetic agent (Parray et al., 2011).  Heretofore the 
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consensus opinion among anesthesiologists has been that intravenous induction allows 
for greater hemodynamic stability, a necessity in these patients who cannot tolerate 
hypotension.  However, an advantage of mask induction is that pain and anxiety 
associated with intravenous line insertion is avoided, making the patient less likely to cry 
and risk the occurrence of an ischemic event.  A case of a moyamoya patient was 
recorded in which crying during intravenous line insertion led to cerebral infarction and 
subsequent hemiparesis, which lasted for 3 months (Nomura et al., 2001).  This study 
hypothesizes that mask inductions provide equal hemodynamic stability for moyamoya 
syndrome patients undergoing anesthesia for pre-operative cerebral angiography 
anesthesia. 
 Although moyamoya syndrome is a rare condition, it is relatively common at 
Boston Children’s Hospital due to the pioneering pial synangiosis indirect 
revascularization neurosurgery developed by Dr. R. Michael Scott.  Therefore, a large 
pool of data is available and this case-series is one of the largest published moyamoya 
studies. A retrospective study was completed to analyze hemodynamic parameters during 
pre-operative cerebral angiographies with statistical analysis of mask induction versus 
intravenous induction groups.  Researchers found this study to be necessary so that 
significant data is available to demonstrate the safety of mask induction for anesthesia for 
moyamoya patients, especially in children.  As explained previously, the disease state of 
the cerebral vasculature makes patients vulnerable to dangerous ischemic events peri-
operatively.  Researchers in this study are confident that if mask induction is equally safe 
to IV induction it should be used preferentially in the pediatric population to help avoid 
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stress and subsequent crying which is an established trigger for ischemic events in 
moyamoya patients (Figure 3).    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Physiological Response to Crying.  This figure depicts the 
series of events that may happen subsequent to an episode of crying.  
Although this is non-remarkable in most patients, it may lead to a serious 
event such as TIA or stroke in a moyamoya patient due to there markedly 
low cerebral blood flow and basally constricted vessels due to occluded 
lumens.  This study seeks to establish mask induction as an equally safe 
alternative to IV induction with the advantage of avoiding crying 
associated with IV usage. 
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OBJECTIVES 
 The objective of this study is to determine if anesthetic mask induction and 
intravenous anesthesia induction result in equal hemodynamic stability in moyamoya 
patients undergoing cerebral angiography.  Our aim is to demonstrate the safety of mask 
induction in this population, which would allow for this option in anxious or 
uncooperative children, thus avoiding crying and hyperventilation related to intravenous 
access. It is critical to avoid hyperventilation in moyamoya patients because it can lead to 
hypocapnea and a subsequent physiological response of vasoconstriction and decreased 
cerebral blood flow.  Due to the baseline cerebral vascular occlusion in moyamoya 
patients any trigger of vasoconstriction must be avoided or patients are placed at risk of a 
further decrease in cerebral blood flow.  A further consideration is that a severe drop in 
blood pressure, which can happen during anesthetic induction can reduce cerebral blood 
flow, leading to a dangerous ischemic event such as TIA or stroke.   
Currently, there is no standard of care for method of anesthetic induction during 
the necessary diagnostic cerebral angiography procedure for the moyamoya patient 
population, although informal conversation reveals a prejudice among anesthesiologists 
in favor of intravenous induction.  This procedure is performed prior to the 
revascularization surgery to visualize occluded vessels and stage the patient’s disease.  
This study seeks to prove that mask induction using sevoflurane is equally safe compared 
to intravenous induction using propofol for cerebral angiography in moyamoya patients 
 17 
and to make recommendations towards establishing this method as the standard of care.  
This hypothesis will be addressed by retrospectively analyzing hemodynamic parameters 
and perioperative complications in moyamoya patients treated between 2007-2012, 
grouped by method of anesthetic induction.  This study also seeks to create a database of 
holistic patient data so that more case series may be carried out in the future.  Although 
valuable data such as demographics and patient profiles including comorbidities may 
reveal interesting trends, the data pool must be larger to draw significant conclusions. 
 
Specific Aims 
Determine if mask induction and intravenous induction of anesthesia are equally safe 
from a hemodynamic perspective for patients with moyamoya syndrome undergoing 
diagnostic cerebral angiography.  This will be accomplished by retrospective analysis of 
hemodynamic, demographic, and other intraoperative data points during induction period.  
Hemodynamic data points include:  blood pressure measured as mean arterial pressure, 
heart rate, temperature and end tidal CO2 during the induction period.   
 Other data points for analysis include  
1. Anesthetic method of induction and drug use 
2.  Pre-operative administration of midazolam  
3. NPO (nothing per oral) time 
4. Fluids and blood products administered (cc/kg)  
5. Weight (kg) 
Demographic data points evaluated include sex, age, race and ethnicity. 
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 The data points referenced above will be used to determine if there is a significant 
difference in percentage blood pressure drop during the anesthetic induction period.  
 
METHODS 
Data Collection  
 Institutional Review Board (IRB) permission was obtained to retrospectively 
access medical charts of patients with moyamoya syndrome who underwent diagnostic 
cerebral angiography prior to pial synangiosis revascularization surgery at Boston 
Children’s Hospital between the years of 2007-2012.  Due to the nature of this study, 
there are no research related interventions or treatments and no identification of 
individual subjects, therefore, consent was not required from the subjects.   
 Each patient’s medical record was reviewed in a careful and systematic manner.  
General patient demographic information was gathered including age, weight, 
race/ethnicity, and existence of comorbidities.  Next, the record was searched for a set of 
preoperative vital signs including temperature, heart rate, and blood pressure.  Following 
this, the anesthesia record of the cerebral angiography procedure was analyzed.  Data was 
collected from the anesthetic induction period of the procedure, which was established 
after consulting with clinicians as the first 30 minutes of the anesthetic procedure.  Data 
points collected from this intraoperative time period include temperature, heart rate, 
blood pressure, and end tidal CO2, NPO time, and fluid and/or blood products 
administered.  
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 This study’s focal point of analysis was blood pressure as a measure of 
hemodynamic stability.  Therefore, two data points measuring blood pressure were 
collected.  First, an average blood pressure throughout the 30-minute induction period 
and also the lowest blood pressure point during induction was recorded.  These values 
were compared to the patient’s baseline blood pressure recorded preoperatively.  The data 
was assessed to see if there was a drop greater than 20% below the baseline blood 
pressure, a drop of this magnitude is considered clinically significant.  This study used 
the patient’s own baseline vitals instead of age-adjusted vital norms for several reasons. 
First, normalized values are not applicable to the moyamoya population due to their 
chronic vascular occlusion.  As a physiological response, blood pressure may be basally 
elevated in an attempt to increase cerebral perfusion; therefore many patients may have 
blood pressures higher than normal.  Therefore, a blood pressure drop which would be 
deemed clinically insignificant when judged on the baseline derived from normal patients 
could be hemodynamically dangerous in moyamoya patients and lead to dangerous 
ischemic events.  Also, in the operating room clinicians reference the preoperative vital 
signs when assessing patient progress throughout the procedure, so, this point of 
comparison was deemed more clinically relevant.  
 Blood pressure data points recorded on the anesthesia record during the procedure 
are denoted in the form of systolic/diastolic values.  Baseline vitals were recorded as a 
mix of either mean arterial pressure (MAP) or systolic/diastolic.  The value of interest in 
this study was MAP.  Therefore, all blood pressures, which were denoted in the 
anesthetic record in the form of systolic/diastolic, were then converted to MAP using the 
 20 
same formula in order to maintain consistency and accuracy.  The following standard 
cardiovascular physiology formula was used for this data conversion (Berne and Levy, 
2010).  
    
  

MAP  Pd 
1
3
(Ps Pd )  
 
After data collection was complete, patients were divided into two groups for 
analysis based on method of induction, mask or intravenous anesthesia.  The key point of 
analysis was comparing the incidence rate of a blood pressure drop greater than 20% of 
baseline value.  Following this analysis, other variables were assessed in an attempt to 
elucidate factors contributing or predisposing to potentially dangerous blood pressure 
drops in moyamoya patients.  
 
Statistics 
Power analysis indicated that a minimum of 112 patients in each of the two 
groups (IV and mask) will provide 80% power to establish equivalence of the incidence 
of a clinically significant drop of 20% or more in MAP within a clinical margin of 5 mm 
Hg using a two group test of equivalence of proportions and an one-sided alpha level of 
0.05 (version 7.0, nQuery Advisor, Statistical Solutions, Saugus, MA). 
Abbreviations: 
MAP: Mean Arterial Pressure 
Pd: Diastolic Pressure 
Ps: Systolic Pressure 
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Statistical analysis will include univariate comparisons between the IV and mask 
groups using Student t-test. 
 Using a drop in MAP of 20% or greater as criteria for assessing safety, we will 
perform analysis will compare IV and mask routes of anesthesia administration with 
respect to the incidence of this pre-defined clinically significant decrease in MAP.  In 
addition to analysis of population proportions, magnitude of blood pressure drops will 
also be analyzed using Student t-test.  Lastly, t-test will also be performed to assess 
differences between the two modes of anesthesia based on the raw data in units of mm 
Hg.  Differences in the incidence of significant drop in MAP will be also evaluated using 
a 95% confidence interval.  Variable data will be analyzed on the bases of population 
proportions with the Student t-test when the group size (n) allows.  Statistical analysis 
will be performed using SPSS version 19.0 (SPSS Inc./IBM, Chicago, IL).      
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RESULTS 
Population Information 
 
 
 Patient data for all moyamoya syndrome patients undergoing cerebral 
angiography from 2007-2012 was reviewed.  After the pre-operative, diagnostic cases 
were identified, the total number of patients (n) was 98, divided equally between male 
and female patients.  Lastly, the race/ethnicity of patients was recorded for the patient 
population (Table 3). 
 
Table 3. Demographics Summary.  The table below shows the demographic 
make-up of the population of moyamoya syndrome patients studied. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Demographics Summary 
Sex   n % of population 
Male  49 50.0%   
Female  49 50.0%   
Total  98 100.0%   
       
Ethnicity n % of population 
Asian 8 8.2%   
Black/African- 
American 9 9.2%   
Caucasian 53 54.1%   
Hispanic/Latino 2 2.0%   
Other/No Reply 26 26.5%   
Total   98 100%   
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For data analysis purposes, patients were divided into two groups based on 
anesthetic induction method, either IV induction using propofol or mask induction using 
sevoflurane.  Each of these groups had n=49 patients.  In order to assess safety 
equivalence among the two induction techniques, each patient was evaluated and 
classified as either a case or a control based on blood pressure.  In order to be a case, the 
patient’s average mean arterial pressure during the anesthetic induction period dropped 
from their pre-operative baseline by more than 20%.  In the IV group (n=49) there were 
35 control patients and 14 cases.  In the mask group (n=49), there were 37 controls and 
12 cases (Table 4). 
 
Table 4. Data Summary.  The table below summarized the patient population 
analyzed in this study.  Additionally, it shows how many patients were the groups 
being evaluated, controls versus cases.  Case patients underwent an unsafe blood 
pressure drop (greater than 20% drop from baseline) during the anesthetic 
induction period. 
 
 
  
 
 
Equivalence of Safety Assessments 
  In order to determine equivalence of safety based on the occurrence of cases in 
each group, the proportion of patients that dropped over 20% from their baseline blood 
pressure was determined (Table 5).  Additionally, the cases were evaluated to determine 
on average how large the blood pressure (BP) drop was.  When analyzing the IV 
Table 4: Data Summary 
Induction Method Anesthetic Agent Total Controls Cases 
IV Propofol 49 35 14 
Mask Sevoflurane 49 37 12 
Total   98 72 26 
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induction group (n=49), the rate of occurrence of cases was 28.6% (Figure 4).  On 
average, the cases experienced a drop of 25.9% from baseline MAP during the induction 
period, with a standard deviation (SD) of 12.1% (Table 5, Figure 5).  Next, when 
analyzing the mask group (n=49), the rate of occurrence of cases was 24.5% (Figure 4).  
On average, the cases experienced a drop of 30.3% from baseline MAP during the 
induction period, with a standard deviation of 6.7% (Table 5, Figure 5).  The rate of 
occurrence of cases in the IV group versus mask group was statistically insignificant as 
measured by a p value of 0.65.   Additionally, the average blood pressure drop 
experienced by patients in the IV versus mask induction group was also not statistically 
significant with a p value of 0.07.  
Table 5. Occurrence of Cases by Average Intraoperative Induction BP.  This table 
shows a summary of case incidence in the two groups analyzed as well as the average BP 
drop experienced.  The p values were derived from a t-test and showed not statistically 
significant difference between the two groups for rate of occurrence or average BP drop. 
 
 
 
 
 
 
 
Table 5: Occurrence of Cases by Average Intraoperative Induction BP 
Group Rate of Occurrence Avg. BP Drop  SD 
IV/Propofol 28.6% 25.9% 12.1% 
Mask/Sevoflurane 24.5% 30.3% 6.7% 
 p=0.65 p=.07  
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Figure 4. Rate of Case Occurrence.  This figure shows the rate of case 
occurrence based on average blood pressure drop during anesthetic induction 
period.  There was no significant difference between IV and mask induction 
(p=0.65).  
 
 
Figure 5. Average Blood Pressure Drop.  This graph shows the difference in 
the average blood pressure drop during the anesthetic induction period in patients 
under IV versus mask induction.  No significant difference was found (p=0.07), 
and therefore, statistically the blood pressure drops can be interpreted as equal 
amongst the two patient populations. 
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To further investigate equivalence of safety, a second type of case was defined.  
For this instance the definition of a case was if the single lowest recorded blood pressure 
point during the induction period, instead of the average, was 20% or more below the 
baseline blood pressure.  When assessing groups for this type of case, the rate of 
occurrence in the IV group was 59.2% versus 53.1% in the mask group.  This difference 
was not statistically significant as measured by a p value of 0.54. On average, the IV 
group cases’ lowest blood pressure point was 29.9% lower than baseline with a standard 
deviation of 6.4% and the mask group cases were 31.9% lower than baseline with a 
standard deviation of 10.1% (Table 6).  The difference in magnitude of the average BP 
drop was also not statistically significant, measured by a p value of 0.57.  
 
Table 6. Occurrence of Cases by Lowest Blood Pressure.  This table shows analysis 
based on lowest single blood pressure during induction period.  Again, there was no 
significant difference in rate of cases or in the magnitude of average BP drop between the 
IV and mask groups. 
 
 
 
 
 
  
 
Lastly, after analyzing the data based on proportions, the groups were evaluated 
using the raw blood pressure data based on MAP as measured in units of mm Hg.  First, 
each group, IV and mask, was evaluated as a whole.  The IV group (n=49), had an 
Table 6: Occurrence of Cases by Lowest Blood Pressure 
Group Rate of Occurrence Avg. BP Drop  SD 
IV/Propofol 59.2% 29.9% 6.4% 
Mask/Sevoflurane 53.1% 31.9% 10.1% 
 p=0.54 p=0.57  
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average baseline MAP of 79 mm Hg.  The average MAP during the intraoperative 
induction period was 69 mm Hg and therefore an average drop of 10 mm Hg (Figure 6).  
The mask group (n=49) had an average pre-operative baseline of 78 mm Hg, average 
induction BP of 69 mm Hg, and therefore, an average drop of 9 mm Hg (Figure 6, Table 
7).  The groups as a whole showed no statistical difference in baseline or average 
intraoperative induction period BP with p values of 0.64 and 1.00, respectively.  
 Next, the cases in which the average MAP during the intraoperative induction 
period dropped 20% or more from baseline were also evaluated using raw data.  The IV 
group cases (n=14), had an average baseline MAP of 84 mm Hg and subsequent average 
induction period MAP of 62 mm Hg.  Therefore, on average, IV cases dropped 22 mm 
Hg from their baseline blood pressure (Figure 7).  The mask cases (n=12), had an average 
baseline MAP of 85 mm Hg, average induction period MAP of 59 mm Hg, and therefore, 
average MAP drop of 26 mm Hg (Figure & Table 7).   Again, the IV versus mask cases 
showed no statistically significant difference in baseline or average intraoperative 
induction period BP as measured by values of 0.8 and 0.46, respectively.   
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Table 7. Blood Pressure Data Summary- in mm Hg.  This table shows analysis based 
on raw data for MAP in mm Hg.  Key data points were the average baseline MAP and 
average IO MAP.  Statistical analysis and p values are based on t tests performed. 
*IO- intraoperative induction period  
 
 
 
 
Table 7: Blood Pressure Data Summary- in mm Hg 
All patients 
Group n Avg. Baseline MAP SD 
Avg. IO* 
MAP SD 
Avg. MAP 
Drop   
IV/Propofol 49 79 mm Hg 11 69 mm Hg 10 10 mm Hg   
Mask/Sevoflurane 49 78 mm Hg 10 69 mm Hg 10 9 mm Hg   
   p=0.64  p=1.0     
Cases 
Group n Avg. Baseline MAP SD 
Avg. IO* 
MAP SD 
Avg. MAP 
Drop   
IV/Propofol 14 84 mm Hg 12 62 mm Hg 13 22 mm Hg 
Mask/Sevoflurane 12 85 mm Hg 7 59 mm Hg 5 26 mm Hg 
  p=0.8  p=0.46   
All patients v. Cases 
IV/Propofol  p=0.03     
Mask/Sevoflurane  p=0.00     
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Figure 6. Average Blood Pressure Drop- in mm Hg.  This graph depicts the average 
blood pressure drop experienced between baseline point and induction period in the IV 
versus mask group.  There was no statistically significant difference at either point 
(p=0.64, 1.0) 
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Figure 7. Average Blood Pressure Drop in Cases.  This graph depicts the average 
blood pressure drop experienced between baseline point and induction period in the IV 
versus mask group when solely analyzing case patients.  There was no statistically 
significant difference at either point (p=0.80, 0.46).  
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Interestingly, when comparing IV induction case patients versus the IV group as a 
whole, there was a significant difference in baseline MAP.  Patients who were cases and 
therefore experienced an unsafe BP dropped had an average baseline BP of 84 mm Hg 
compared to 79 mm Hg for the group as a whole.  This was deemed significant by a p 
value of 0.03.  In mask cases versus the whole group there was also a significant 
difference with a p value of 0.00 (Table 7). 
 
Variable Analysis  
 During data collection, variables in addition to hemodynamic data were collected 
and analyzed for possible correlation in control patients versus case patients who 
experienced what is clinically deemed as an unsafe blood pressure drop.  
 First, the patient data was grouped by age into two groups.  The first group was 
patients less than 10 years old and there were 69 patients in this group.  Of the 69 
patients, 23 underwent IV and 46 underwent mask anesthetic induction.  The next group 
was patients 10 years old or older, and this group had 29 patients.  Of the 29 patients, 26 
underwent IV and 3 underwent mask anesthetic induction (Table 8). 
 Additionally, the cases in which average intraoperative induction period MAP 
dropped by 20% or more from baseline were also grouped based on patient age.  When 
analyzing case patients under the age of 10 (n=15), the rate of occurrence of cases was 
21.7% when using both IV and mask induction.  In total, 57.7% of cases occurred in 
patients under the age of 10.  In case patients 10 years old or older (n=11), the rate of 
occurrence of cases was 34.6% under IV induction and 66.7% under mask induction.  In 
total, 42.31% of all cases occurred in patients 10 years old or older (Table 8).   Based on 
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t-tests, the difference in rate of cases when IV induction used in younger versus older 
children was not statistically significant, measured by a p value of 0.32.  This analysis 
could not be performed for mask induction because in older children the sample size was 
too small (n=3).  Additionally, the rate of cases, regardless of induction method, was not 
statistically different in older versus younger children as measured by a p value of 0.26. 
 
Table 8. Data Summary by Age Group.  This table shows analysis when the 
patient population was separated into two age groups, under 10 years old and 10 
years old or older.   Furthermore, the age groups were also analyzed based on 
anesthetic induction method.  
 
 
  
 
 
 
 
 
 
 
The next variable analyzed was whether or not an anti-anxiety premedication, 
Midazolam, was administered prior to anesthetic induction.  Out of the entire patient 
cohort (n=98), Midazolam was administered to 49 patients, or 50%.   In patients 
undergoing IV induction (n=49), the premedication was administered 69.4% of the time, 
and in patients undergoing mask induction (n=49), it was administered 30.6% of the time.  
Table 8: Data Summary by Age Group 
Summary           
Age n IV Mask       
< 10 years old 69 23 46     
> 10 years old 29 26 3     
         
Cases             
Age n IV Rate Mask Rate Total Rate 
< 10 years old 15 5 21.7% 10 21.7% 57.69% 
> 10 years old 11 9 34.6% 2 66.7% 42.31% 
   p=0.32  p=n/a p=0.26 
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Next, only the cases were analyzed for administration of Midazolam.  When looking at 
all cases (n=26), regardless of induction method, 11 (or 42.3%) of patients did receive 
Midazolam, and 15 (or 57.7%) of case patients did not receive Midazolam (Table 9).  
Statistically speaking, there was no difference in rate of occurrence of patients between 
the group that did receive the premedication Midazolam and the group that did not 
(p=0.27).  
 
Table 9. Midazolam usage.  First, this table shows the rate of administration of 
Midazolam in patients induced using IV and mask methods.  Next, it analyzes the 
rate of administration in all cases, regardless of induction method.  There was no 
significant difference in occurrence of cases when Midazolam was/was not 
administered.  
 
 
 
 
 
 
  
 
 
Additionally, administration of nitrous oxide during anesthetic induction was also 
analyzed.   Of the entire patient cohort (n=98), it was administered to 51 patients.  Of 
patients who received nitrous oxide (n=51), 13 (or 25.49%) were cases in which the 
average intraoperative induction period blood pressure dropped 20% or more from 
baseline.  Of patients who did not receive nitrous oxide (n=47), 13 were cases (or 
Table 9: Midazolam Usage 
In all patients    
IV/Propofol 34 69.40% 
Mask/Sevoflurane 15 30.60% 
     
In all cases    
yes 11 42.30% 
no 15 57.70% 
  p=0.27 
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27.66%) (Table 10).  Statistically speaking, administration of nitrous oxide had no 
significant effect of the rate of case occurrence, measured with a p value of 0.81. 
  
  
Table 10. Nitrous Oxide Usage.  This table first shows the number of patients 
who did/did not receive nitrous oxide during anesthetic induction.  Additionally,  
it shows the number of cases and the corresponding occurrence rate of cases, 
which was not significantly different based on administration of nitrous oxide. 
 
 
 
 
 
 
Also, the variable of nothing per oral time (NPO) was analyzed.  NPO is defined 
as the number of hours prior to the surgery in which the patient has had no food or drink.  
The patient cohort was analyzed as a whole to assess if there was a correlation between 
the number of NPO hours and the percent change in blood pressure as compared to 
baseline.  When plotted, the data revealed that there was no correlation (R
2
=2E-05) 
between these two data points (Figure 8).  
Table 10: Nitrous Oxide Usage  
Usage Total Cases Rate 
Yes 51 13 25.49% 
No 47 13 27.66% 
   p=0.81 
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Figure 8: NPO time v. Blood Pressure Change.  This scatter plot shows that no 
correlation between NPO time and percent change in blood pressure was found. 
 
 
Lastly, the patient records were reviewed to find the existence of comorbidities, 
chronic conditions experienced by the patient in addition to moyamoya syndrome.  Of the 
98 total patients, 25 had an existing comorbidity and 73 did not.  The rate of occurrence 
of cases in patients with comorbidity was 36% versus 23.3% in patients with no other 
chronic illness.  The specific illnesses were also noted (Table 11), and they overlap with 
the conditions cited in literature (Table 1) as common comorbidities in moyamoya 
patients.  Although this data is noteworthy, it could not be evaluated statistically due to 
the small sample size. 
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Table 11. Incidence of Comorbidities in Patients.  This table shows the number and 
corresponding rate of case occurrence in patients when grouped based on the existence of 
a chronic comorbidity.  Also, it shows the frequency of the most common cormorbidities 
observed in the patient cohort. 
 
Table 11: Incidence of Comorbidities in Patients 
Classification Total Cases Rate 
Existing Comorbidity 25 9 36% 
No other illness 73 17 23.3% 
     
Specific Comorbidities     
Down's Syndrome 4 2 50.0% 
Irradiation Exposure 11 4 36.4% 
Neurofibromatosis Type 1 1 1 100.0% 
Sickle Cell Anemia 8 1 12.5% 
Von Willebrand Disease 1 1 100.0% 
 
 
The results obtained in this study allowed for a multi-faceted evaluation of 
clinical safety associated with different induction methods in moyamoya syndrome 
patients.  Moving forward, the results have important implications in regard to the care 
and treatment of these patients. 
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DISCUSSION 
 
Results 
 
 The key data analysis in this study involved evaluating equivalence of safety 
assessments for IV and mask anesthetic inductions in moyamoya patients undergoing 
diagnostic cerebral angiograms.  This was the key aspect of this study and therefore was 
studied from different approaches to ensure that it was equally safe from every 
perspective.   
 First, this was analyzed by comparing proportions of the patient populations that 
were deemed “cases” due to an average induction period blood pressure drop of 20% or 
greater from their baseline blood pressure.  This comparison showed that the proportion 
of cases in IV and mask induction groups was statistically equivalent.  Furthermore, to 
ensure that something was not missed, a second class of case was devised.  This time, 
patients were labeled as “cases” if their single lowest blood pressure point, instead of 
average, during the induction period dropped 20% or more from baseline.  Again, the 
proportion of patients in the IV versus mask group who experienced this clinical event 
was statistically equivalent.  
 Following evaluation based on patient proportions, the raw data for blood 
pressure points in units of mm Hg was analyzed.  Again, the data for IV versus mask 
groups was proved to be statistically equivalent.  One statistically significant difference 
was found, however.  For both IV and mask groups, patients who were cases based on 
average blood pressure drop had a significantly higher baseline blood pressure when 
 38 
compared to the IV and mask groups as a whole.  Although initially counterintuitive, this 
intriguing result reveals something noteworthy.  The patients who experienced unsafe 
hemodynamic changes during anesthetic induction had on average, a significantly higher 
baseline blood pressure.  This could indicate that their moyamoya syndrome was more 
advanced and a physiological compensation of increased blood pressure was occurring.  
Moving forward, it would be valuable to research the Suzuki stage of each patient and 
search for a possible correlation between stage and blood pressure drop.  
 Conclusively, all equivalence of safety assessments demonstrated that mask is 
equally safe to IV induction as measured by blood pressure drops during the anesthetic 
induction period.  Based on this study’s hypothesis being proven, it is recommended that 
mask induction be considered equally safe and potentially preferable for moyamoya 
patients undergoing diagnostic cerebral angiograms. 
 In addition to safety assessments, different operative variables were analyzed.  Of 
the variables analyzed, none were shown to have a statistically significant effect on the 
magnitude or frequency of average blood pressure drop during the intraoperative 
anesthetic induction period.  These variables included age, midazolam usage, nitrous 
oxide usage, NPO time, and existence of a chronic cormorbidity.  Some of these variables 
could not be assessed for statistical meaning due to small sample sizes, and this is an 
example of something that could be addressed in the future.   
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Future Directions 
 
The main source of limitation in this study was a small patient cohort (n=98).   
Despite being one of the largest case series studies on moyamoya patients, the small 
number of patients made some statistical analysis impossible to perform.  For example, a 
power analysis could not be performed because this would have required a patient cohort 
of 224 patients for 90% power.  Additionally, as noted in the results, when analyzing 
based on age group, t-test could not even be performed for the mask induction patients 
due to small sample size.  
Moving forward, maintaining the current data set and enrolling additional patients 
as they are seen at Boston Children’s Hospital is the best strategy.  Eventually, enough 
data will be available to surpass the current limitations on analysis.  An interesting part of 
analysis that could not be statistically evaluated was the rate of occurrence of cases based 
on the presence or absence of a chronic comorbidity in addition to moyamoya.  Future 
analysis of these patients is essential because if a trend in anesthetic safety is found it 
would be feasible to set the standard of care for patients with moyamoya and comorbidity 
“x”.   
For now, knowing that mask induction is equally safe to IV induction for 
diagnostic cerebral angiograms is very important and it is hoped that future studies may 
reveal more data trends that can improve the care of moyamoya patients.  
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CONCLUSION  
 In conclusion, the hypothesis behind this study was proven to be correct in that 
mask induction is a statistically proven, equally safe method for anesthetic induction 
when compared to IV induction when moyamoya patients are undergoing diagnostic 
cerebral angiograms.  Due to the hemodynamic complications that could possible arise 
due to crying and anxiety associated with IV insertion and access in pediatric patients, 
this study strongly recommends that mask induction be considered equally safe and 
possibly preferential to IV for this patient population during this specific procedure.  
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